Introduction {#s1}
============

Bacteria belonging to the Enterobacteriaceae genus *Photorhabdus* exist in a symbiotic partnership with entomopathogenic *Heterorhabditis* sp. nematodes. This Entomopathogenic Nematode complex (EPN) comprises a highly efficient symbiosis of pathogens that is commonly used as a biological agent to control crop pests ([@bib15]). The *Photorhabdus* bacteria are delivered into the hemocoel of the insect, after regurgitation from the worm, where they resist the insect immune response and rapidly kill the host via septicaemic infection. Insect tissues are subsequently bio-converted into a dense soup of *Photorhabdus* bacteria, which provide a food source to support the replication of the nematode. As food resources are depleted *Photorhabdus* re-associates with infective juvenile nematodes, and together they emerge from the insect cadaver able to re-infect a new host ([@bib7]; [@bib48]). Three major species have been formally recognized to date within the genus - *P. luminescens*, *P. asymbiotica*, and *P. temperata*. It should be noted however that with increasing numbers of *Photorhabdus* genome sequences becoming available, the genus structure is under revision ([@bib35]). In addition to the normal insect life cycle, *P. asymbiotica* is also the etiological agent of a serious human infection termed *Photorhabdosis*, which is associated with severe ulcerated skin lesions both at the initial infection foci and later at disseminated distal sites ([@bib19]; [@bib20]; [@bib17]; [@bib18]).

The *Photorhabdus* genome encodes a diverse repertoire of virulence genes encoding for protein toxins, proteases and lipases for combating diverse hosts, that can be found in chromosomally encoded pathogenicity islands ([@bib60]; [@bib13]; [@bib56]; [@bib10]; [@bib61]; [@bib62]). In addition, the bacteria also secrete a potent cocktail of other biologically active small molecules to preserve the insect cadaver in the soil from competing saprophytes and microbial predators such as amoeba ([@bib5]; [@bib3]). Several classes of *Photorhabdus* protein insecticidal toxins have now been well characterised including the Toxin Complexes ([@bib14]; [@bib54]; [@bib55]; [@bib37]; [@bib12]; [@bib59]; [@bib23]), the binary PirAB toxins ([@bib58]; [@bib1]; [@bib47]) and the large single polypeptide Mcf ('makes caterpillars floppy') toxins ([@bib8]; [@bib57]; [@bib9]).

A fourth class of highly distinct toxin delivery systems first identified in *Photorhabdus* are the '*Photorhabdus* virulence cassettes', or PVCs ([@bib64]). These represent operons of around 16, conserved, structural and synthetic genes (from hereon just described as the structural genes) encoding for a phage 'tailocin' like structure ([@bib21]) and one or more tightly linked downstream toxin-effector like genes. Genomic analysis of multiple strains of *Photorhabdus* revealed they often encode up to five or six copies of the operon, each with unique downstream effector genes ([@bib22]).

It should be noted that PVC-like elements are not restricted to *Photorhabdus* as a well-characterized homologous operon can also be found on the pADAP plasmid of the insect pathogenic bacteria *Serratia entomophila* ([@bib26]). This system has been named the anti-feeding prophage (AFP), as it is responsible for the cessation of feeding in the New Zealand grass grub host. Recent cryo-electron microscopy studies have revealed that, morphologically, AFP resembles a simplified version of the sheathed tail of bacteriophages such as T4, including a baseplate complex. It also shares features with type-VI secretion systems, with the central tube of the structure having a similar diameter and axial width to the Hcp1 hexamer of *P. aeruginosa* T6SS ([@bib24]). One important difference between the PVC and T6SS machinery is that the T6SS relies upon direct contact between host and bacterial cell, and is anchored in to the membrane by a substantial membrane complex whose structure is still being elucidated ([@bib11]), whereas the PVC needle complex is freely released into the surrounding milieu and so can act at a distance.

Furthermore, recent reports have indicated that other more diverse bacteria can also make similar needle complexes for manipulation of eukaryotic hosts. A well-characterized example is the production of analogous devices by the marine bacterium *Pseudoalteromonas luteoviolacea* ([Figure 1A](#fig1){ref-type="fig"}). These structures are involved in the developmental metamorphosis of the larvae of the tubeworm *Hydroides elegans,* and they are deployed in outward-facing arrays comprising about 100 contractile structures, with baseplates linked by tail fibres in a hexagonal net ([@bib45]). Interrogation of sequence databases with PVC protein sequences suggests many other more diverse tailocin-like systems are yet to be characterized ([@bib42]). These include operons closely related to the PVCs in *Xenorhabdus bovienii* CS03, *Yersinia ruckeri* ATCC29473 and *Vibrio campbellii* AND4. In addition, evidence of more diverse elements, like that of *P. luteoviolacea*, can also be seen. To address this, we have recently performed an exhaustive analysis of all available prokaryotic and archaeal genome sequences in the public databases to look at the distribution of *pvc*-like elements (unpublished data). This suggests that PVC-like nano-syringes and their distant cousins are of enormous ecological and perhaps biomedical significance.

![Genetic organisation of PVC operons.\
(**A**) Similarity between PVCs and two diverse protein secretion systems, (i) the *P. luteoviolacea mac* gene cluster and (ii) The type-VI secretion system (T6SS) from *Burkholderia mallei. *Homologous protein sequences are coloured coded. (**B**) Three classes of PVC structural operons observed in the genomes of *Photorhabdus* and members of other genera. Classes 1--3 are exemplified by PVC*pnf*, PVC*lopT* and PVC*PaTox* respectively. Homologous genes are colour coded. Red vertical arrows represent variations relative to the representative class I PVC*pnf* operon of *P. asymbiotica* ATCC43949 (genes *pvc1*-PAU_03353 to *pvc16*-PAU_03338). Predicted functions of individual Pvc proteins based on homology to known proteins can be seen in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. The boxed 'GGCGGTAGNNT' or 'CAGGTTGXTGCGGTAGCTAT' sequences represent positions of the conserved RfaH anti-termination protein and cryptic operator sequences respectively. Square brackets above certain genes indicate apparent translational coupling. More specifically; \*one indicates coupling in PVC*pnf* and PVC*cif* of *Pl*^TT01^, *Pa*^ATCC43949^, *Pa*^PB68^ and *Pa*^Kingscliff^ and in the *Serratia entomophila afp* operon in addition to an uncharacterised PVC in *Yersinia ruckeri* ATCC 29473. \*\*one indicates these genes are not coupled in *Pa*^Kingscliff^. \*two indicates coupling in PVC*lopT* of *Pl*^TT01^, *Pa*^ATCC43949^, *Pa*^PB68^ and *Pa*^Kingscliff^. \*\*two indicates these genes are not coupled in *Pa*^Kingscliff^. \*three indicates coupling in PVC*Patox* of *Pa*^ATCC43949^and *Pa*^Kingscliff^ (although *pvc11* possibly contains a frame-shift in *Pa*^Kingscliff^). The *pvc3* is also deleted in *Pa*^Kingscliff^.](elife-46259-fig1){#fig1}

Here we focus on a single *Photorhabdus pvc* operon (which elaborates the PVC*pnf* needle complex ([@bib64]) to understand the relationship between the structural genes and the tightly linked effector gene, *pnf*. We confirm in vivo expression during insect infection and reveal a high level of population heterogeneity of expression in vitro. We demonstrate for the first time the physical association of the Pnf effector toxin protein with the secreted structural needle complex using Western blot and electron microscopy. Furthermore, we prove that the cognate Pnf effector needs to be delivered into the eukaryote cell cytoplasm to exert any measurable effect and confirm its predicted activity targeting small Rho-GTPase target proteins. Taken together this work describes an important new class of protein toxin secretion and injection delivery systems which, unlike the well-described Types III, IV and VI systems, can act 'at a distance', requiring no intimate contact between bacteria and host cells.

Results {#s2}
=======

A bioinformatic analysis of *pvc* structural operon sequences {#s2-1}
-------------------------------------------------------------

A comparison of *pvc* structural operons identified in the genome sequences of *Photorhabdus* and certain members of other genera, available at the time of publication ([@bib10]; [@bib62]; [@bib63] and our unpublished data), allowed us to define three distinct genetic sub-types. The PVC*pnf* operon belongs to class I, which has 16 structural genes and three translationally coupled gene blocks, and is of the type typically seen in non-*Photorhabdus* genera. Class II and III operons differ in the number of structural genes and translationally coupled gene blocks ([Figure 1B](#fig1){ref-type="fig"}). Given the diversity of *pvc*-operons, and their typically poor annotation in genome sequences, it is necessary here to define a nomenclature protocol to allow reference to any given operon. An example of the method we have adopted is as follows; \[*Pa* ^ATCC43949^ PVC*pnf*\], where *Pa* ^ATCC43949^ is species and strain, in this case *Photorhabdus asymbiotica* strain ATCC43949 and PVC*pnf* is the specific operon within that genome with the suffix referring to one of the tightly linked effectors, in this case the *pnf* effector gene. We will also include gene identifiers for either end of the operon where appropriate, which in this case would be PAU_03353-PAU_03332, which are the genes for *pvc1* and *pnf* respectively.

With reference to published literature and a detailed bioinformatic analysis of promoter regions upstream of the *pvc1* genes, we can identify two distinct, potential *cis*-operator sequences. Firstly operons belonging to classes I (e.g. PVC*pnf*) and III (e.g. PVC*PaTox*) typically encode the highly conserved RfaH operator sequence, GGCGGTAGNNT ([@bib2]). RfaH is a conserved anti-termination protein that is known to regulate large operons encoding for extracellular factors in *E. coli*. It is also believed to be important in ensuring appropriate transcriptional control of horizontally acquired operons ([@bib2]). Many of the *pvc*-operons in *Photorhabdus* and members of other genera (including *Xenorhabdus* and *Yersinia*) encode this operator sequence. An unusual example is the pADAP plasmid encoded *Serratia entomophila* anti feeding prophage (*afp*) ([@bib26]). While the *afp* promoter also encodes an RfaH operator sequence, it has been demonstrated that it is positively regulated by a tightly linked specific regulator protein, AnfA1 ([@bib27]; [@bib25]). This protein is a distant homologue of RfaH suggesting that other class I or III *pvc* operons are not necessarily under the regulation of the chromosomal RfaH orthologue, but might also be controlled by other diverse regulators that utilise this same operator sequence ([@bib6]). Unfortunately, we were not able to directly test the role of RfaH in *pvc*-regulation as attempts to knock out the single *P. luminescens* TT01 *rfaH* gene were not successful, suggesting an essential role. Secondly, all class II operons (e.g. PVC*lopT*) and certain class I operons (e.g. PVC*units*1-4) encode a minimal cryptic conserved sequence motif, CAGGTTGXTGCGGTAGCTAT. In both cases these conserved *cis*-encoded sequences are located between the *pvc1* gene and the transcription start sites, as defined by previous RNA-seq analysis ([@bib39] and unpublished data). We speculate that this motif, which we have so far only found in *pvc* loci, may represent an operator sequence for a cryptic regulator.

Although there is no experimental evidence, several observations suggest that horizontal gene transfer may have been responsible for the dissemination of many observed *pvc*-operons. These include; the presence of four *pvc* operons in tandem in *P. luminescens* TT01 (directly adjacent to a type IV DNA conjugation pilus operon), the presence of multiple *pvc* operons in any given genome, the suggestion that several operons are regulated by RfaH and the remnants of YhgA-like IS elements and inverted repeats (IR) associated with many of the operons (e.g. the IR sequence 5'-TTATATTGAA(t/g)GAATATTAAGCAAGAAAC-3' flanking \[*Pl*^TT01^PVC*u4*\]). Nevertheless, automatic prediction of horizontal gene transfer regions (HGTs) using Alien Hunter 1.7 ([@bib53]) either did not detect any HGT elements spanning the structural regions of PVCs or in the cases where such an element was detected it was assigned a low confidence score ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

An analysis of the conservation of individual genes across different *pvc* operons at both DNA and protein sequence levels suggests that either recombination or diversifying selection is more likely to have occurred in the more 3' regions of the operons ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This is perhaps no surprise as each *pvc* operon can be seen to encode different effector genes in the 3' payload region of the operons. An analysis of conservation of protein sequences of the *pvc* operons showed that within *pvc*-operons a good deal of variability is possible while presumably retaining the ability to produce a similar macromolecular structure ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). This is supported by HHPRED structural homology comparisons for equivalent PVC proteins across different operons, despite often-variable primary amino acid sequences (data not shown). We note that the most diverse protein seen in *pvc*-operons is that of the predicted tail fibre proteins, Pvc13, which we may expect if different *pvc*-operons are adapted for different host cell targets. Paralogous genes within *pvc*-operons include *pvc1* and *pvc5* which encode homologs of Hcp, the inner tube protein of contractile tube mechanisms such as T6SS and phage protein Gp27 and *pvc2*, −*3* and −*4* which encode homologues of the outer sheath proteins of phage ([@bib34]) and T6SS ([@bib41]). [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} illustrates the organisation of the \[*Pa*^ATCC43949^ PVC*pnf*\] operon used as a model system in our experimental studies described here, showing the top HHPRED structural homology hits and predicted roles for each encoded protein at the time of writing.

A bioinformatic analysis of *pvc*-operon effector gene sequences {#s2-2}
----------------------------------------------------------------

A comparison of the 3' effector 'payload regions' of different *pvc* operons reveals a large diversity of effector genes, with a range of predicted activities, covering a large range of sizes and isoelectric point values (data not shown). Some operons encode only a single putative effector, for example \[*Pa*^ATCC43949^ PVC*PaTox* PAU_02249--02230\] while others have several, either tandem homologues of one another, for example \[*Pa*^ATCC43949^ PVC*u4* PAU_02790--02808\] or entirely unrelated putative effector genes, for example \[*Pa*^ATCC43949^ PVC*lopT* PAU_02112--02095\]. Many effector genes are also tightly linked to transposase gene remnants suggesting they are typically exchanged by horizontal acquisition. This is further supported by the observation that orthologous *pvc*-operons in the same chromosomal context may have different effector genes in different strains. A good example of this being the unrelated effector genes seen in the orthologous structural 'PVC*pnf*' operon loci of *Pa^Kingscliff^* and *Pa*^ATCC43949^ which carry a tyrosine glycosylase and Pnf (this paper) respectively. Analysis with Alien Hunter 1.7, suggests that certain *pvc*-operon/effector associations are ancestral to any given species. For example, the association of the *pvc17* effector with PVC*u4*, and the multiple linked effectors with the PVC*lopT* operon in both *Pa*^ATCC43949^ and *Pl*^TT01^. Conversely other *pvc*-operons show evidence of recent horizontal acquisition of their 3'linked effectors, for example PVC*cif* and PVC*pnf* (not shown).

Expression of PVC*pnf* in vitro and in vivo {#s2-3}
-------------------------------------------

A previous RNA-seq analysis of global transcription in three strains; *P. asymbiotica* ^ATCC43949^ ([@bib39]), *P. asymbiotica*^Kingscliff^ and *P. luminescens* ^TT01^ (unpublished) showed condition dependent expression of certain *pvc*-operons but not all. Therefore, due to the diversity of *pvc* operons and effectors in *Photorhabdus*, we focused on a single model class I *pvc* operon, \[*Pa*^ATCC43949^ PVC*pnf*\], to elucidate the relationship between the conserved structural and effector proteins. This operon was selected as it elaborates a well-defined needle complex structure (as observed by electron microscopy) which has potent insect killing activity when heterologously expressed in *E. coli* ([@bib64]). This operon has two putative effector genes in the downstream 'payload region', PAU_03337, which shows similarity to adenylate cyclase toxins (e.g. the anthrax Edema Factor and Pseudomonas ExoY toxin) and *pnf* (PAU_03332). While the predicted activity of PAU_03337 has not been tested directly, when expressed in the NIH-3T3 cell cytoplasm (in transient transfection experiments) it did produce a highly unusual cytoskeleton phenotype ([@bib64]). Pnf ([P]{.ul}hotorhabdus [n]{.ul}ecrosis [f]{.ul}actor) is a homologue of the active site domain of the *Yersinia* CNF2 (Cyto Necrosis Factor 2) toxin, which has small-GTPase deamidase and transglutaminase activities ([@bib33]).

In order to confirm the expression of this model *pvc*-operon in *Photorhabdus* during an insect infection we constructed transcription-translation reporter plasmids in which the promoter regions and the first 150 bp of coding sequence of *pvc1*, *pnf* \[both from *Pa*^ATCC43949^ PVC*pnf*\] and the *P. asymbiotica* chromosomal *rpsM* ribosomal 'housekeeping' gene (as a positive control) were genetically fused in frame to a *gfpmut*2 gene with no start codon (referred to hereon as *pvc1::gfp, pnf::gfp* and *rpsM::gfp* reporters). Note, the genomic context and our previous unpublished RT-PCR studies suggested that *pnf* had its own promoter and could be transcribed independently of the *pvc* structural genes. As we are unable to transform *Pa*^ATCC43949^ itself, these plasmids were transformed into the well-characterised and genetically tractable strain *P. luminescens*^TT01^ to provide suitable reporter strains for in vitro and in vivo expression studies. For in vitro studies we cultured the bacteria in LB medium supplemented with *Manduca sexta* clarified hemolymph and grown to late stationary phase, before microscopic examination ([Figure 2A](#fig2){ref-type="fig"}). For in vivo studies, we injected a low inoculum (c.a. 100 CFU) of the reporter strains into *M. sexta,* and allowed the infection to establish for 12 hr before macroscopic examination of insect tissues in situ using a (fluorescence) dissecting microscope. We also took hemolymph samples from these insects and visualised the hemocytes and bacteria microscopically using confocal microscopy. This approach provides confidence that the cells showing *gfp* expression are those in the process of a normal productive infection rather than those carried through in the inoculum.

![Examination of PVC operon expression using *gfp* reporter constructs in *Photorhabdus*.\
(**A**) Confocal micrographs of showing in vitro (**A1--A3**) and in vivo (**B1--B3**) expression in *Pl*^TT01^ of *gfp* transcription-translation reporter constructs of *Pa*^ATCC43949^ PVC*pnf* operon gene promoters. These plasmid-based reporters were constructed by fusing the transcription promoter regions and the first 37 codons of the target gene in frame with the second codon of *gfp*. Target gene promoters shown are (**A1 and B1**) the constitutively expressed *rpsM* gene, (**A2 and B2**) the *Pa*^ATCC43949^ PVC*pnf pvc1* structural gene and (**A3 and B3**) *Pa*^ATCC43949^ PVC*pnf pnf* payload toxin gene. The in vitro panels (A1-3) show reporter expression after growth in LB supplemented with 20% (v/v) 5^th^ instar *M. sexta* hemolymph at late stationary phase. The in vivo panels show ex vivo hemolymph from 5^th^ instar *M. sexta* infected with *Pl*^TT01^ harbouring the three different reporter constructs. The hemocyte cytoskeletons are stained red with TRITC-Phalloidin conjugate. (**B**) White light (left) and fluorescence illumination (right) of the trachea of a dissected 5^th^ instar *M. sexta* previously infected with *Pl*^TT01^ harbouring the *Pa*^ATCC43949^ PVC^pnf^*pnf::gfp* reporter construct. Brightly fluorescent green bacteria were detected in association with the trachea (red arrow) in close proximity to melanotic nodules (white arrows) at 12 hr post infection, demonstrating the induction of the *pnf* promoter and the production of the Pnf::GFP fusion in situ. Bars show 0.1 mm.](elife-46259-fig2){#fig2}

[Figure 2A](#fig2){ref-type="fig"} shows expression of GFP reporter from the *rpsM* positive control and both the *pvc1::gfp* and *pnf::gfp* reporters in LB supplemented with *M. sexta* hemolymph, although not in all cells of the bacterial population (see below). Furthermore, we also saw expression in bacteria in the ex vivo hemolymph samples taken during infection of live insects ([Figure 2A](#fig2){ref-type="fig"}). It was also possible to confirm expression of *pnf::gfp* in bacteria attached to the insect trachea in localised putative biofilm masses. In this case, while the expected insect melanisation immune response could be seen to have occurred elsewhere on the trachea, it was notably absent from the *pnf* expressing bacterial biomass ([Figure 2B](#fig2){ref-type="fig"}).

We subsequently expanded this analysis to include a panel of transcription-translation reporter plasmids for different PVC operons from two different species of *Photorhabdus*. We cloned around 500 bp of the 5' regions (containing the promoter, translation initiation region and first ATG of *pvc1* translationally fused to *gfp*) of *P. luminescens*^TT01^; PVC*unit1*, PVC*unit4*, PVC*lopT* and PVC*cif* and from *P. asymbiotica* ^PB68.1^; PVC*pnf*, PVC*unit*, PVCl*opT* and PVC*cif* (see supplementary file 'Reporter construct primers'). Each of the eight reporter constructs were then transformed into the relevant *Photorhabdus* strain and examined using fluorescent microscopy to assess the expression patterns across growth phases, when grown in LB with aeration and maintaining plasmid marker selection. We initially focused on the *P. asymbiotica* ^PB68.1^ \[PVC*pnf*\] reporter strain as it represents an orthologue of the *P. asymbiotica* ^ATCC43949^ PVC*pnf* operon, which is the model operon central to this report. We observed a high level of population heterogeneity in expression, usually with only very few cells expressing GFP at any one time ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Image analysis provides an objective assessment of heterogeneity, and small percentage of cells expressing Gfp, and thus the *pvc*-operon ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Interestingly, a similar pattern of heterogeneity in expression was seen for the other seven operon reporter constructs from both *Pa*^PB68^ and *Pl*^TT01^ ([Figure 2---figure supplements 3](#fig2s3){ref-type="fig"} and [4](#fig2s4){ref-type="fig"}). Note in certain cases we saw no expression at all (e.g. the PVClopT operon of *Pa*^PB68.1^), which fits with the low or lack of mRNA expression seen in a previous in vitro RNAseq study for the majority of *pvc*-operons (upublished data). We also assessed expression in biofilms grown statically on glass slides and observed the same pattern, though with even fewer cells seen to express GFP (not shown).

In order to corroborate the observations made using the plasmid-based reporter constructs in *P. luminescens* ^TT01^ during infection we also performed RT-PCR analysis of transcription of the PVC*pnf* chromosomal operon in the original *Pa*^ATCC43939^ strain. This confirmed transcription across the operon in vitro when the bacteria were grown at either 28**°**C or 37**°**C, although transcription of certain genes was difficult to detect in vivo during *Manduca sexta* infections ([Figure 3](#fig3){ref-type="fig"}).

![Confirmation of the PVCpnf-operon transcription in vitro and in vivo using RT-PCR.\
(**A**) RT-PCR analysis of gene transcription of various genes of the *Pa*^ATCC43949^ PVC*pnf* operon over time in vitro at insect (28°C) and human (37°C) relevant temperatures and in vivo during *Manduca sexta* (*Ms*) infection. Lane key; lanes 1, 2 and 3 (blue) represent in vitro growth in aerated LB at 28°C for 4, 8 and 24 hr respectively; lanes 4, 5 and 6 (red) are growth in aerated LB at 37°C for 4, 8 and 24 hr; lane 7 (black) is growth in LB at 28°C for 16 hr; lanes 8 and 9 (green) are from 3 hr and 6 hr post infection blood of *Ms* infected with *P. asymbiotica* at 28°C. (**B**) Map of the operon showing RT-PCR target genes in black. The lane-colour coded bars above the ORFs summarise in which conditions gene transcription could be detected. Note *pvc8* and *pvc14* mRNA could not be detected from infected *Ms* and the *pnf* mRNA was only detected after 6 hr of infection. (**C**) RT-PCR signals for *pvc15* and *pnf* from infected insects with the *rpsM* (ribosomal subunit protein S13) loading control. Lanes represent (in order); 4 hr growth in LB at 28°C; 4 hr growth in Grace's insect medium supplemented with 20% (v/v) Ms hemolymph; 3 hr and 6 hr post infection ex vivo blood of *Ms* infected with *P. asymbiotica* at 28°C.](elife-46259-fig3){#fig3}

The Pnf effector protein is physically associated with the PVC needle complex {#s2-4}
-----------------------------------------------------------------------------

We investigated if the Pnf effector protein actually becomes physically associated with the *pvc*-encoded needle complex we had previously visualised by electron microscopy ([@bib64]). While a recent publication has described a cryo-EM structure of this particular PVC needle complex ([@bib29]), they did not include expression of an effector. In order to investigate if the complex does indeed physically associate with a cognate effector, we raised anti-peptide antibodies against synthetic peptides representing amino acids 206--219 of effector Pnf (TGQKPGNNEWKTGR) and amino acids 130--143 (DGPETELTINGAEE) of the predicted outer sheath protein Pvc2. We then used these antibodies to probe PVC*pnf* needles expressed from cosmid clones in *E. coli*. Previously we used 2D-SDS PAGE analysis of PVC*pnf* needle complex produced by these same cosmid clones to confirm the presence of Pvc2, along with Pvc1, 3, 5, 11, 14 and 16 proteins ([@bib64] and unpublished data). We confirmed specificity of the Pnf antibody using western blot analysis of extracts of *E. coli* heterologously expressing Pnf alone.

We first used the anti-Pnf peptide antibody to test for the presence of Pnf protein in supernatants from the native bacterial strain *Pa*^ATCC43949^. We initially tested for the presence of Pnf in clarified supernatants and particulate preparations of stationary phase cultures. Previous studies reporting successful detection of *Photorhabdus* secreted insecticidal toxins under similar conditions.

We could detect Pnf in preparations enriched for the complexes but not in clarified supernatants. More specifically, the Pnf protein could only be detected in the needle complex fraction of wild-type *Pa*^ATCC43949^ which was isolated from 250 ml overnight cultures using DEAE-Sepharose chromatography but not in concentrated supernatant collected from a culture grown from the same starter and under the same conditions. The toxin could only be detected if the needle complexes were first either chemically or physically disrupted before electrophoresis ([Figure 4B](#fig4){ref-type="fig"}). Taken together these findings are consistent with the hypothesis that the Pnf protein is sequestered inside the needle complex or in some other configuration such that the TGQKPGNNEWKTGR epitope is physically hidden from access by the antibody. There is still the potential that the toxin is released in the supernatant but at not detectable amounts in these conditions.

![Pnf protein can only be detected in discharged or disrupted needle complexes using antibody based analysis.\
(**A**) Representative images of immuno-gold stained transmission electron microscopy grids confirming the Pnf-payload toxin is associated with the needle complex. PVC*pnf* needle complexes (PVC-NC) were prepared from supernatants of the *E. coli* 4df10 cosmid clone, which encodes the PVC*pnf* operon. We used anti-peptide antibodies against Pvc2 (DGPETELTINGAEE) and Pnf (TGQKPGNNEWKTGR) epitopes to localise these protein subunits. The Pvc2 epitope appeared to only become accessible to the antibody when subunits were 'broken off' the ends (white arrows). The Pnf toxin could also only be detected at the ends of broken or contracted suggesting they are contained within the complex (black arrows). (**B**) Western blot analysis confirms that the Pnf protein can only be detected using the anti-peptide antibody if the needle complex is either chemically or physically disrupted. These preparations were taken from *Pa*^ATCC43949^ supernatants. The inability to detect Pnf in clarified supernatants confirms all the protein is associated with the PVC-NC enrichment preparation. Lanes 1 + 5; sonicated samples, 2 + 6; 1M NaCl treatments, 3 + 7; 1% SDS treatments 4 + 8; 1M Urea treatments. Note the PVC-NC appears stable in 1M NaCl.](elife-46259-fig4){#fig4}

Secondly, we enriched needle complexes from insect toxic supernatants of an *E. coli* cosmid clone that encodes the *Pa*^ATCC43949^ PVC*pnf* operon, as previously described ([@bib64]). The anti-Pnf antibody was used for in situ labelling of Pnf on Transmission Electron Microscopy grids, visualised with negative staining and an anti-rabbit gold-conjugate secondary antibody. It was only possible to detect Pnf protein near the ends of either contracted or damaged needle complexes ([Figure 4A](#fig4){ref-type="fig"}). Note we saw no non-specific labelling when the gold-conjugate secondary antibody was used alone. As the full cryo-EM structure of this model PVC*pnf* was recently published, it allowed us to examine the location of the epitope we used to raise and anti-peptide antibody to the main outer sheath component Pvc2. While the epitope should indeed be surface exposed based on our analysis, we nevertheless only saw an anti-Pvc2 signal associated with what appeared to be disrupted fragments of needle complexes. We therefore surmise that the secondary structure of Pvc2 in the intact needle abolishes antibody binding to the epitope we selected.

The Pnf protein requires delivery into the eukaryotic cell cytoplasm to exert its effect {#s2-5}
----------------------------------------------------------------------------------------

In a previous publication we reported that injection of an enriched *Pa*^ATCC43949^ PVC*pnf* needle complex preparation; heterologously produced by an *E. coli* cosmid clone, caused melanisation and death of *Galleria mellonella* larvae within 30 min. In addition, microscopic analysis of phalloidin stained hemocytes taken from these dying animals revealed the cells were shrunken with highly condensed cytoskeletons, and likely already dead. This effect was abolished by heat denaturing the preparation. In this same publication ([@bib64]) we demonstrated that transient cytoplasmic expression of the Pnf protein caused extensive cytoskeleton re-arrangement and likely cell death in cultured Human HeLa ATCC CCL2 cells, similar to that observed in the ex vivo G. mellonella hemocytes. In an attempt to directly visualise the interaction of the heterologously produced PVC*pnf* needle complex with insect hemocytes and to determine the initial effects on the cellular morphology, we injected intact or heat denatured PVC*pnf* needle complex preparations into 5^th^ instar *Manduca sexta* larvae before bleeding the animals and preparing their circulating hemocytes for surface examination by cryo-SEM. The surface of hemocytes taken from insects that had been injected with intact complex showed membrane ruffling consistent with the predicted mode of action of the Pnf protein (see below). Furthermore, we could also see linear structures approximately 150 nm in length on the surface of the cells near the sites of membrane ruffles consistent with attached needle complexes. The surface of the control hemocytes taken from insects that had been injected with heat-denatured complex remained relatively smooth and homogeneous and we saw no equivalent linear structures. [Figure 5](#fig5){ref-type="fig"} shows representative images from these experiments.

![Visualisation of PVC needle complexes on the cell surface.\
Cryo-SEM analysis of ex vivo hemocytes from 5^th^ instar *Manduca sexta* that had been injected with (**A**) native or (**B**) heat inactivated enriched preparations of *Pa*^ATCC43949^ PVC*pnf* needle complexes heterologously produced by the *E. coli* cosmid clone. Note the abundant linear structures believed to be the PVC needle complex (yellow arrows) and membrane ruffling effect (red arrows) absent from the control treatment.](elife-46259-fig5){#fig5}

We wished to know if the Pnf effector could exert this toxic effect independently of the needle complex, when applied externally to eukaryotic cells. Therefore, we heterologously expressed (in *E. coli*) and purified the Pnf protein in addition to a predicted toxoid derivative. The wild-type Pnf protein and toxoid derivative were purified using HisTrap Ni^2+^-affinity columns with the fast phase liquid chromatography (FPLC) AKTA system as described in the methods. SDS-PAGE was used to confirm high levels of purity and that no obvious degradation had occurred. The toxoid was designed based on homology between Pnf and the CNF2 toxin active site, wherein we mutated the cysteine at amino acid position 190 into an alanine (Pnf ^C190A^). Firstly, neither purified wild type nor toxoid proteins had any obvious toxic effect when injected into cohorts of *G. mellonella*, even at high doses (data not shown). We subsequently used bioPORTER, a liposome based transfection system, to introduce the purified proteins directly into cultured human cells. We visualised effects on the cytoskeleton and nucleus using TRITC-phalloidin and DAPI staining respectively. The wild type Pnf protein had a very clear effect on the cells, producing phenotypes consistent with those predicted by similarity to the CNF2 toxin. CNF2 is known to modify the cellular Rho GTPases, RhoA, Rac1 and Cdc42. Pnf delivery as a bioPORTER formulation led to the formation of F-actin filaments within 24 hr followed by multi-nucleation by 48 hr, phenotypes consistent with the modification of the Rho GTPases. The toxoid derivative, delivered at the same dose using the same approach, produced no changes, giving cellular phenotypes consistent with that of the negative control or of the wild-type Pnf protein topically applied without the bioPORTER transfection agent ([Figure 6](#fig6){ref-type="fig"}). Computational secondary structure predictions of the toxin and toxoid were performed to assess the potential impact of the C190A active site amino acid substitution using the Phyre2 algorithm. We obtained structural predictions (100% confidence score) based on similarity to the known structure of a *E. coli* CNF1/2 family toxin active site domain (PDB Entry: 1hq0), which revealed only very minor predicted changes ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

![Pnf needs to gain access to the host cell cytoplasm to induce F-actin formation and multi-nucleation in cultured HeLa cells.\
Wild-type and inactive toxoid mutant Pnf protein was delivered topically using BioPORTER. Cell cytoskeleton is stained with TRITC-Phalloidin and the cell nuclei with DAPI. This gave rise to phenotypes consistent with the molecular targets and that of the *Yersinia* CNF2 protein homologue. Note we see the F-actin formation by 24 hr (white arrows) preceding extensive multi-nucleation of the host cell by 48 hr (yellow arrows). Note neither application of the Pnf toxoid in a BioPORTER formulation or the purified wild-type Pnf protein without BioPORTER had any observable effect on the cells.](elife-46259-fig6){#fig6}

The pnf protein effector modifies small rho GTPases {#s2-6}
---------------------------------------------------

Based on homology to CNF2 the effect of Pnf on target cell proteins is predicted to include the modification of several Rho-family GTPases. Therefore, we used western blot assays to examine in vitro transglutamination and deamidation effects of purified heterologously produced Pnf on purified small GTPases RhoA, Rac1 and Cdc42. The RhoA, Rac1 and Cdc42 were purified from *E. coli* heterologous expression strains using GSTrap HP affinity columns with the FPLC AKTA system in accordance with previously published protocols, as described in the methods. SDS-PAGE analysis was used to confirm good levels of purity and lack of any significant degradation. Transglutamination is the formation of a covalent bond between a free amine group, as may be found on a lysine residue, and the gamma-carboxamide group of glutamine. As a result protein electrophoretic mobility of the protein is altered. Deamidation is a chemical reaction in which an amide functional group is removed from the protein, which may be detected using deamidated protein specific antibodies. These experiments demonstrated that Pnf induced transglutamination and deamidation of both RhoA and Rac1 ([Figure 7](#fig7){ref-type="fig"}), although unlike the reported activity of CNF2, had no effect on Cdc42. As predicted the active site toxoid mutant had no enzymatic activity on any of the three Rho GTPases confirming it was a true toxoid derivative.

![Pnf transglutaminates and deamidates purified mammalian RhoGTPAses at Gln63 (RhoA) and Gln 61 (Rac1).\
(**A**) For transglutamination assays a 2:1 molar ratio of small Rho GTPase to purified Pnf was incubated in transglutamination buffer in the presence of ethylediamine for 1 hr at 37°C. Note transglutaminated GTPase runs slightly slower on the gel as visualised using anti RhoA and Rac1 antibodies. (**B**) For deamidation assays a 20:1 molar ratio of Rho GTPases; RhoA and Rac1, to purified Pnf toxin was incubated in deamidation buffer for either 30 min or 2.5 hr at 37°C. Note deamidation is detected using an antibody specific towards deamidated Rho GTPase antigens. In both cases, the wild-type Pnf protein was active (solid arrows) while a site directed amino acid C190A toxoid mutant (in the predicted Pnf active site) showed no activity (dotted arrows).](elife-46259-fig7){#fig7}

Discussion {#s3}
==========

An analysis of the different subunit proteins of PVCs shows they share several elements in common with other contractile phage-tail derived systems, including the Type VI secretion system (T6SS) ([@bib32]) and to a lesser extent R-type pyocins ([@bib50]). However, PVC-like elements are distinct in two important ways. Firstly, unlike the T6SS, they require no membrane complex for anchoring and synthesis and are freely released from the producing bacterial cell. Therefore, in common with R-type pyocins, they can act at a distance. Secondly, like T6SS but unlike R-type Pyocins, they are evolved to inject bioactive protein effectors into other cells. We hypothesise that the PVCs are evolved to specifically target eukaryotic cells, unlike T6SS, which have been shown to be able to deliver to both eukaryotes and prokaryotic competitors. However, while our previous attempts to show PVC*pnf* attachment to a range of bacterial species from different genera showed no binding we could detect (data not shown), we cannot rule out the possibility that homologues exist which are able to target prokaryotes.

We speculate that these large protein complexes are costly for the cell to produce, consistent with the observation of population heterogeneity of *pvc*-operon expression. Indeed, uncontrolled heterologous over expression of the *Pa*^ATCC43949^ PVC*lopT* and PVC*pnf* operons in cosmid clones in *E. coli*, results in deletion of regions of the *pvc*-operon (confirmed by sequencing) and significant loss of culture viability (not shown). It should be noted that in a natural insect infection the vast majority of the *Photorhabdus* bacterial population are sacrificial. The majority of the population act as a food source for the replicating nematodes, with very few cells passing into the next generation of infective juvenile nematodes ([@bib7]). As such the population may restrict PVC production to a limited number of sacrificial cells. We have noted the presence of holin-lysin gene homologues tightly linked to certain *pvc*-operons, including both 5' and 3' to the *Pa*^ATCC43949^ PVC*pnf* operon which we focus on in this publication. Release by cell lysis would be consistent with the proposed method of release of the related MAC arrays of *Pseudoalteromonas* ([@bib45]). Nevertheless, to date we have not directly observed any cell lysis associated with *pvc* expression in *Photorhabdus* itself.

The finding that *Pa*^ATCC43949^ PVC*pnf,* and seven other *pvc*-operons from *Pa*^PB68^ and *Pl*^TT01^ (not shown) all show population heterogeneity in expression, at least in vitro, suggests that they are likely deployed in a highly regulated and conservative manner. While it is difficult to fully characterise this heterogeneity in vivo, the PVC*pnf* GFP reporter strain did show restricted expression to one specific tissue, the insect trachea, and not throughout the body of the animal. In regards to these experiments, it should be noted that we did not see any melanisation response around the bacterial biomass showing GFP. The insect melanisation immune response is typically activated at sites of encapsulation. This is mediated by the recruitment of hemocytes, surrounding and enclosing foreign bodies, and entombing them in melanin. The absence of melanisation around this GFP expressing bacterial mass is consistent with the expression of anti-hemocyte virulence genes, which are likely to include the native *Pl*^TT01^ *pvc*-operons.

Examination of the promoter regions has provided no clue as to the mechanism of population heterogeneity of expression. Nevertheless, the identification of RfaH and a second cryptic conserved potential operator sequence upstream of the *pvc1* genes provides a starting point for addressing this in future. Operons containing the second cryptic putative regulatory sequence include \[*Pl* ^TT01^PVC*lopT*\] and \[*Pl* ^TT01^ PVC*u4*\]. Analysis of the supplementary data from a recently published RNA-seq study ([@bib52]), suggests that these operons may be dependent upon Hfq/HexA activity ([@bib30]).

Unlike many of the other genera in which we see *pvc*-like operons, *Photorhabdus* genomes encode multiple copies, typically around 5 to 6, suggesting they play important and diverse roles in the life cycle. With this in mind, we examined the conservation of the different subunit genes between operons. We observe a 'break point' in conservation, toward the 3' end of the operons. We postulate this may be due to imprecise recombination events in the 3' payload regions of *pvc*-operons, where incoming sequences, which have a GC-content that is distinct from the host genome, gradually 'erode' the upstream sequence. Alternatively, it is plausible that the lower GC at the distal end of these long operons (each of \~25 kb) may assist in strand separation during transcription, maintaining stoichiometry for these large, multi-subunit structures. Indeed low GC stretches of DNA are common origins of replication because of their reduced strand separation energy ([@bib36]). However, as yet we do not know whether the *pvc1* promoter serves the whole operon, or if there are additional promoters internal to the operon.

Each of the *pvc*-operons in a *Photorhabdus* genome encodes multiple paralogous copies of *pvc1/5* and *pvc2/3/4* genes. We were therefore surprised not to see any operons showing signs of genetic degradation. This suggests there is sufficient positive selection for maintaining these multiple operons, with each operon potentially adapted for a specific role. This hypothesis is supported by the high variation in the Pvc13 protein sequences, which we speculate represent the host cell binding fibres. The need to maintain multiple copies of *pvc*-operons may also have arisen if the structural genes for the needle complexes are specifically adapted for delivery of their cognate *cis*-linked effector proteins in some way.

Circumstantial evidence from genomic sequences and previous work on the related AFP system of *Serratia* has suggested the needle complexes serve to deliver the *cis*-encoded effector proteins. We present here for the first time direct evidence that a linked effector protein does in fact become physically associated with the needle complex. Western blot detection of Pnf from preparations enriched for needle complexes taken from the native *Pa*^ATCC43949^ supernatants confirmed it was being expressed in vitro and suggested it was physically associated with the complexes. In addition, physical or chemical disruption was required to release the Pnf protein for detection. When taken alongside the immuno-gold EM observations, showing Pnf could only be seen near contracted or damaged needle complexes, it confirms the protein is either sequestered inside the complex or physically associated in such as way that the TGQKPGNNEWKTGR epitope is not solvent accessible. The anti-Pvc2 antibody is able to specifically detect the protein in Western blots, however it only showed binding to what appeared to be disrupted fragments of needle complexes, again suggesting the relevant epitope is not accessible in the intact native needle complex structure. Indeed, iTasser structural model simulations of a PVC outer sheath Pvc2 protein, using the homologous *Pseudomonas* 3J9Q PDB structure of an R-type pyocin outer sheath as a model ([@bib16]), supports this idea, suggesting the epitope is partially occluded between adjacent subunits.

While we have not yet directly demonstrated injection of Pnf into host cells by the needle complex, the results of the topical application and bioPORTER transfection experiments confirmed that the Pnf effector absolutely requires a mechanism to facilitate entry into the host cell cytoplasm to exert its effect. We argue the evidence for injection by the needle complex is very strong, and is corroborated by the SEM visualisation of needle-like structures of the correct dimensions on the surface of intoxicated hemocytes. Finally, we have confirmed that Pnf acts in a manner similar to the *Yersinia* CNF2 toxin, modifying two of the same Rho-GTPases, which correlates with the observed phenotypic effects on the cell.

Materials and methods {#s4}
=====================

Insects, bacterial strains and growth conditions {#s4-1}
------------------------------------------------

*Manduca sexta* (Lepidoptera: *Sphingidae*) were individually reared as described ([@bib40]). Briefly, larvae were maintained individually at 25°C under a photoperiod of 17 hr light: 7 hr dark and fed on an artificial diet based on wheat germ. Larvae 1 day after ecdysis to the 5th instar were used for all experiments. Batches of wax moth larvae (75 g; Livefood UK Ltd, Rooks Bridge, UK) in their final instar stage were stored in the dark at 4°C and used within a week of receipt. DH5α *E. coli* (containing various plasmid constructs) were grown on LB agar at 37°C or in LB liquid, shaking at 200 rpm. Spontaneous rifampicin-resistant mutants of *Photorhabdus asymbiotica subsp. asymbiotica* Thai (strain PB68.1) ([@bib51]) and *Photorhabdus luminescens subsp. laumondii* TTO1 ([@bib10]) were used in these studies as hosts for reporter plasmids. *Photorhabdus* were routinely cultured in LB broth or on LB agar supplemented with 0.1% (w/v) pyruvate at 30°C or 37°C (for *P. asymbiotica*). When required antibiotics were added at the following concentrations: ampicillin (Amp): 100 µg ml^−1^, kanamycin (Km): 25 µg ml^−1^, chloramphenicol (Cm): 25 µg ml^−1^, rifampicin (Rif): 25 µg ml^−1^. Human adenocarcinoma HeLa ATCC CCL2 cells (obtained from ATCC culture collection -- mycoplasma free) were cultured for 10 passages in Dulbecco's modified Eagle medium (Sigma-Aldrich) containing 4.5 g/L glucose (Sigma-Aldrich), 10% heat-inactivated fetal bovine serum (Sigma-Aldrich), 2 mM glutamine (Sigma-Aldrich), 100 μg /mL penicillin, and 100 μg/mL streptomycin (Sigma-Aldrich) and incubated at 37°C and 5% CO~2~.

PVC gene reporter plasmid construction {#s4-2}
--------------------------------------

Translational fusions with the *gfpmut*2 gene were constructed by PCR in a pACYC184 vector containing the *gfpmut*2 (pACYC-GFP) ([@bib28]) as follows. The *pvc1*, *pnf and rpsM* genes (consisting of promoter regions and the first 150 bp of coding sequence) were amplified from *P. asymbiotica* ^ATCC43949^ genomic DNA and cloned into pACYC-*gfp* to generate pACYC-*afp1-gfp*, pACYC-*pnf-gfp* and pACYC-*rpsM-gfp*. The constructs were further digested to release the *pvc1*, *pnf or rpsM* genes in frame with *gfp* and the fusion fragments were cloned into pBBR1-MCS ([@bib31]) to generate pBBR1-*pvc1-gfp*, pBBR1-*pnf-gfp* and pBBR1-*rpsM-gfp*. Mating experiments were performed as previously described ([@bib4]) to transfer plasmid constructs into *P. luminescens* ^TTO1^ resulting in *Pl*^TTO1^*-pvc1-gfp*, *Pl*^TTO1^*-pnf-gfp* and *Pl*^TTO1^*-rpsM-gfp*. Plasmid stability was confirmed in bacteria harbouring the various constructs isolated after in vivo passages. For the expanded panel of *gfp*-reporter fusions, the promoter regions for the operons selected, inclusive of the putative RfaH operator sites (if present), and the native RBS and first codon of the *pvc1* gene (approximately 500 bp upstream), were cloned in to the pAGAG vector. pAGAG was derivatised from the promoterless pGAG1 *gfp* bearing plasmid., In brief, pGAG1 was used as a template to amplify *gfpmut3\** without a start codon using primers pG_GFPfor (5'-aatgtcgaccgtaaaggagaagaacttttc) and pG_GFPrev (5'-aatactagtggatctatttgtatagttcatccatg). The resulting product and the pGAG1 vector were cut by digestion with SalI-HF and SpeI and ligated together, thus replacing the original intact *gfpmut3\** gene with one that lacks a ribosome binding site and the first ATG codon. This reporter plasmid backbone was used to construct a panel of specific transcription-translation reporter plasmids for different *pvc*-operon 5' promotor regions. In brief regions 5' to the *pvc1* open reading frames from each operon were PCR amplified from *P. luminescens* strain TT01; PVCunit1, PVCunit4, PVClopT and PVCcif and from *P. asymbiotica* strain PB68.1; PVCPnf, PVCunit, PVClopT and PVCcif. Primers used are shown in Supplementary file 'Reporter construct primers'. All upstream promoter regions were incorporated between the KpnI and BamHI sites of the pAGAG vector. After initial cloning into *E. coli*, correct constructs, as confirmed by DNA sequencing, were transformed into the relevant *Photorhabdus* strain (*P. luminescens* TT01 or *P. asymbiotica* PB68.1) for fluorescent microscopy studies. ([Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}, [2](#fig2s2){ref-type="fig"}, [3](#fig2s3){ref-type="fig"} and [4](#fig2s4){ref-type="fig"}).

Image analysis of reporter strain expression heterogeneity {#s4-3}
----------------------------------------------------------

Quantitative image analysis of micrographs of *P. asymbiotica* PB68.1 harbouring the *Pa*^PB68^ PVC*pnf pvc1* promoter fusion construct was performed using Fiji. Brightfield images were used to automatically detect the bacteria by converting the image to binary, followed by edge detection and particle analysis with the size of the particles set to 0.5--7 μm^2^. The resulting regions of interest when then used to measure the intensity in the corresponding green channel (for GFP detection). At least four images were used per time point with a minimum total number of cells of 450 for each time point. The control consists of images taken of *P. asymbiotica* PB68.1 harbouring the negative control plasmid pAGAG and for the purposes of this analysis the mean intensity per cell calculated for each time point were combined to find a threshold value for subtraction of background fluorescence. For the calculation of the percentage number of green cells for each time point, a threshold of 1200 was used above which there were no control cells with this mean intensity value. Raw data can be seen in [Figure 2---figure supplement 2---source data 1](#fig2s2sdata1){ref-type="supplementary-material"}.

Fluorescent reporter strain assays {#s4-4}
----------------------------------

### In vitro experiments {#s4-4-1}

Reporter strains were cultured with shaking aeration in LB liquid medium supplemented with 20% (v/v) freshly harvested 5^th^ instar *M. sexta* clarified hemolymph. To obtain the hemolymph, insects were chilled on ice for 20 min before being bled (by cutting the tip of the tail horn) into a tube on ice, containing 10 μl of saturated Phenol Thio Urea (PTU) solution, which prevents melanisation. Hemolymph was clarified by centrifugation to remove hemocytes and other debris. Bacteria were grown to late stationary phase, before microscopic visualisation using a Leica inverted epi-fluorescent microscope. In vivo experiments, we injected ca. 100 cells of the reporter strains into cohorts of 5^th^ instar *M. sexta,* and allowed the infection to establish before macroscopic examination of insect tissues using a (fluorescence) dissecting microscope. We also took hemolymph samples from these insects and performed microscopic examination of fixed ex vivo hemocytes stained with phalloidin conjugate and confocal microscopy to visualise host cell cytoskeleton and any GFP expression from the recombinant bacteria. Images were acquired with a LSM510 confocal microscope (Leica).

PVC purification from *E. coli* cosmid clone supernatants and electron microscopy {#s4-5}
---------------------------------------------------------------------------------

Cosmid libraries of *P. asymbiotica* ^ATCC43949^ were prepared in *E. coli* EC100 and arrayed into 96-well microtiter plates by MWG Biotech, Munich, Germany, as described previously ([@bib61]; [@bib8]). A 250 ml overnight culture of *E. coli* with the *Pa*^ATCC43949^ PVC*pnf* cosmid (c4DF10) and a wild-type *Pa*^ATCC43949^ were grown in LB medium supplemented with 100 µg ml^−1^ ampicillin (in case of the cosmid strain) at 28°C with aeration in the dark. The cultures were centrifuged at 6800 x *g* at 4°C for 30 min at 4°C. The supernatants were decanted to remove each cell pellet, and the centrifugation procedure was repeated to remove any remaining cells. Cell-free supernatants were then centrifuged, in small batches, at 150,000 × *g* for 90 min at 4°C to harvest particulate material. The particulate pellets were washed by gentle re-suspension in 1 × Phosphate Buffered Saline (PBS) before a second centrifugation at 150,000 × *g* for 90 min at 4°C to pellet the particulate material. Each pellet was further separated by DEAE-Sepharose chromatography. 10 ml of particulate material in ice-cold PBS were mixed with an equivalent volume of DEAE-Sepharose CL-6B anion exchanger (in PBS) and the preparation was incubated at room temperature for 15 min. The Sepharose resin was harvested by centrifugation (3,000 × *g*), and the supernatant was discarded. The resin was resuspended in 40 ml of ice-cold PBS and again harvested by centrifugation. This washing step was repeated another three times, and the resin was finally resuspended in 10 ml of elution buffer (0.5 M NaCl, 50 mM phosphate buffer \[pH 7.4\]). The resin was removed by centrifugation, and the supernatant containing the PVCs was again centrifuged at 150,000 × *g* for 90 min at 4°C to pellet the particulate material and concentrate the needle structures in 500 μl of ice-cold PBS. For transmission electron microscopy (TEM) pioloform-covered 300-mesh copper grids that were coated with a fine layer of carbon were used as substrates for the protein fractions. The following four aqueous negative stains were tested with the protein samples: 1% uranyl acetate, 3% ammonium molybdate, 3% methylamine tungstate, and 2% sodium silicotungstate. The preferred stain, 3% methylamine tungstate, produced acceptable contrast and minimum artefacts and was subsequently used for all samples viewed by TEM. The coated grids were exposed to UV light for 16 hr immediately prior to use to ensure adequate wetting of the substrate. A 10 μl drop was applied to the TEM grid, and the protein was allowed to settle for 5 min. Liquid was absorbed with filter paper from the edge of the grid and replaced immediately with 10 μl of filtered negative stain. The drop was partially removed with filter paper, and the grids were allowed to air dry thoroughly before they were viewed with a JEOL 1200EX transmission electron microscope (JEOL, Tokyo, Japan) operating at 80 kV.

Production and isolation of secreted Pnf from wild-type *P. asymbiotica*^ATCC43949^ was performed at the same time as the production and isolation of wild-type needle complex in a duplicate culture. Bacterial cultures were grown from the same starter culture and under the same conditions. However, for isolation of secreted proteins, the supernatant was filtered through 0.45 µm and 0.22 µm filters to remove any remaining bacteria and particulate matter. Then it was concentrated using 4% TCA overnight at 4°C and the next morning washed and resuspended in approximately 10 ml of 50 mM Tris-HCl pH 7.4. The secreted proteins were further concentrated using Amicon filters with NMWL of 10 kDa to 500 µl.

Pnf cloning and heterologous expression for *Galleria* injection and antibody specificity test {#s4-6}
----------------------------------------------------------------------------------------------

*Pnf* gene was amplified from *P. asymbiotica* ^ATCC43949^ genomic DNA (using primers Pnf_NdeI 5'-ATATAT[CATATG]{.ul}ATGTTAAAATATGCTAATCCT-3', Pnf_BamHI 5'-ATATAT[GGATCC]{.ul}TTATAACAACCGTTTTTTAAG-3') and the PCR product was purified and cloned in-frame with a His-tag into the IPTG-inducible expression plasmid pET-15b (Novagen) to create construct pET15b-Pnf. The clone was verified by sequencing and transformed into Arctic Express competent cells (Agilent) for protein expression. A site-directed mutant of Pnf (toxoid) was generated with the QuikChange site-directed mutagenesis kit (Agilent). To construct the Pnf mutant plasmid pET15b-Pnf~C190A~, pET15b-Pnf was amplified with FPLC-purified primers designed to generate a Cys to Ala substitution at position 190 (Pnf~C190A~\_for 5\'-TCACCGAATATACCATAGTAGCACCGCTCAATGCTCCAGAC-3', Pnf~C190A~\_rev 5'-GTCTGGAGCATTGAGCGGTGCTACTATGGTATATTCGGTGA-3') using the following thermal profile (step 1: 95°C for 30 s, step 2: 95°C for 30 s, 55°C for 60 s, 68°C for 6 min 45 s for 16 cycles). The identity of six different positive clones was confirmed by sequencing. Subsequently, −80°C glycerol stocks were used to inoculate 5 ml of fresh LB medium supplemented with 0.2% (w/v) glucose and 100 µgml^−1^ ampicillin. Bacteria were grown overnight at 30°C with shaking, and 1 ml of the culture was then harvested, re-suspended in 100 ml of the same medium, and incubated in an orbital incubator at 37°C until the optical density at 600 nm was 0.7 to 0.9. Cells were then harvested at room temperature by centrifugation at 4,000 rpm for 10 min. The pellet was re-suspended in 100 ml of fresh LB medium supplemented with the 100 µg ml^−1^ ampicillin and 0.1 mM of the inducer isopropyl-β-d-thiogalactopyranoside (IPTG). Optimized times for inductions were determined experimentally, and cells were then harvested. The bacterial cell pellet was re-suspended in 10 ml of 1x PBS and sonicated (four 20 s sonications at 45 mA using a Branson 450 digital Sonifier fitted with a tapered probe). The freshly sonicated samples were then diluted in 1x PBS for injection into *Galleria* larvae and for SDS-polyacrylamide gel electrophoresis analysis to confirm expression of the target protein. For toxicity testing cohorts of *Galleria* larvae (n = 20) were chilled on ice before injection with 10 μl of a dilution series (in sterile PBS) of sonicated cells expressing Pnf or vector control. Insects were then returned to room temperature and observed for 5 days or mortality or morbidity.

Recombinant Pnf and small Rho-GTPase purification {#s4-7}
-------------------------------------------------

ArcticExpress containing pET-15b-Pnf were initially grown in LB broth supplemented with 100 µg ml^−1^ ampicillin at 37°C until OD 0.6 when Pnf expression was induced with a final concentration of 0.1 mM of IPTG at 12°C for 16 hr to produce soluble Pnf. Pnf was purified over HisTrap Ni^2+^-affinity column with the fast phase liquid chromatography (FPLC) AKTA system as per the manufacturer's protocol (GE Healthcare). Plasmids pGEX-2T-wtRhoA, pGEX-2T-wtRac1 and pGEX-2T-G25K (Cdc42) were gifts from Prof Alan Hall (University College London, London, UK) and were maintained in *E. coli* DH5α grown on LB agar or in LB broth supplemented with 50 µg ml^−1^ ampicillin. RhoA, Rac1 and Cdc42 were purified over GSTrap HP affinity columns with the FPLC AKTA system as per the manufacturer's protocol (GE Healthcare).

BioPORTER assay and actin stress fibre analysis {#s4-8}
-----------------------------------------------

For BioPORTER assays, 80 µl of purified wild type and mutant Pnf proteins (500 µg ml^−1^), or PBS as a negative control, were added to one BioPORTER tube (Genlantis) and resuspended in 920 µl of DMEM. The samples were added to Human HeLa ATCC CCL2 cells (ATCC collection) grown in 6-well plates and incubated for 4 hr. BioPORTER/protein or PBS mixes were replaced by fresh complete medium and the cells were incubated for 20--48 hr. To visualise cell morphology and actin cytoskeleton, cells were fixed for 15 min in 4% PBS-formaldehyde, permeabilized with 0.1% Triton X-100 and stained with Tetramethylrhodamine B isothiocyanate (TRITC)-phalloidin (Sigma) and DAPI dihydrochloride (Sigma). Images were acquired with a LSM510 confocal microscope (Leica).

Deamidation and transglutamination of Rho GTPases {#s4-9}
-------------------------------------------------

### Deamidation assay {#s4-9-1}

Deamidation assays were done according to previously described procedures ([@bib43]) with the following modifications. Briefly, a 20:1 molar ratio of GTPase (RhoA, Rac1 or Cdc42) to toxin was incubated in deamidation buffer (50 mM NaCl, 50 mM Tris-HCl pH 7.4, 5 mM MgCl~2~, 1 mM DTT, 1 mM phenylmethanesulphonyl fluoride) for either 30 min or 2.5 hr at 37°C. Untreated RhoA served as a negative control. After toxin treatment, samples were concentrated by the addition of 10% trichloroacetic acid and stored overnight at 4°C. Precipitated proteins were pelleted, washed with acetone, air-dried and resuspended in 20 mM Tris-HCl pH 7.4. Samples were subjected to SDS-PAGE and analysed by Western blotting using either an anti-RhoA (1:1500, Santa Cruz Biotechnology), anti-Rac1 (1:5000, Upstate Biotechnology), or anti-Cdc42 (1:1000, Santa Cruz Biotechnology) monoclonal antibody or rabbit polyclonal antisera (1:2000) that had been raised against a peptide antigen specifically designed to detect modified/deamidated RhoA/Rac1/Cdc42 ([@bib49]), provided by Prof A. D. O'Brien, Department of Microbiology and Immunology at Uniformed Services University, Maryland, USA). Reactive proteins were detected with either the HRP-conjugated goat anti-mouse IgG (Sigma) or donkey anti-rabbit IgG (1:3000, Sigma) followed by visualization with DAB (Sigma).

Transglutamination assay {#s4-10}
------------------------

Transglutamination assays were done as previously described ([@bib44]) with several modifications. Briefly, a 2:1 molar ratio of RhoA to toxin was incubated in transglutamination buffer (50 mM Tris-HCl pH 7.4, 8 mM CaCl~2~, 5 mM MgCl~2~, 1 mM DTT, 1 mM EDTA) in the presence of 50 mM ethylenediamine (which raised the pH of the buffer to 9) for 10 min or 1 hr at 37°C. As a negative control, RhoA was incubated with ethylenediamine but without toxin. Samples (0.25 µg RhoA/well) were subjected to SDS-PAGE and then processed for Western blot analyses as described above. Immunoblots were probed with a mouse anti-RhoA monoclonal antibody (1:1500, Santa Cruz Biotechnology) and reactive proteins visualised with DAB after incubation with the HRP-conjugated goat anti-mouse IgG secondary antibody.

A bioinformatic analysis of *pvc* structural operon sequences {#s4-11}
-------------------------------------------------------------

DNA sequences for each of the 16 conserved structural loci were clustered syntenically (all *pvc1*s, all *pvc2*'s etc.). % GC content for each CDS in each syntenic position was calculated (up to 16 observations per locus), and plotted as a boxplot via ggplot2 ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The average GC content across the full operon, as well as for the whole genome, were plotted as intervals in the plot background to show the PVC loci %GC in contrast. The breakpoint was defined by use of the 'cumSEG' package in R ([@bib38]). Amino acid similarity scores ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) were generated by CLUSTAL Omega ([@bib46]) multiple sequence alignment, using default parameters. Resulting pairwise alignment scores were plotted as boxplots using ggplot.

RNA purification and RT-PCR {#s4-12}
---------------------------

For in vitro transcription analysis, overnight cultures of *P. asymbiotica* were sub-cultured into liquid LB medium and grown with aeration at 28°C or 37°C 200 rpm in the dark. Planktonic cultures were collected at 4, 8 and 24 hr and mixed with a double volume of RNAlater (Ambion) and after 5 min incubation, bacteria were harvested by centrifugation and the pellets stored at −80°C. For in vivo transcription analysis, overnight cultures of *P. asymbiotica* were extensively washed in PBS and diluted in Grace's insect media (GIM) to achieve 1000 bacteria per 50 μl of culture. Each *M. sexta* larvae was injected with 50 μl of *P. asymbiotica* culture and they were placed in a humid temperature-controlled room at 28°C. After 3 hr or 6 hr of incubation, insects were bled in equal volume of GIM containing 20 mM phenylthiocarbamide (PTC). The sample was initially fractionated into plasma and total hemocytes by centrifugation at 200 x *g* at 4°C for 5 min, and plasma was further centrifuged at 6800 x *g* at 4°C for 5 min to form a bacterial pellet. For each condition, total RNA was extracted using the RNeasy Mini Kit (Qiagen) and 2 μg total RNA was treated with TURBO DNA-free Kit (Ambion) and subjected to RT-PCR using the Qiagen OneStep RT-PCR kit. Each RT-PCR reaction performed in a volume of 50 μl (containing 100 ng template RNA, 1x QIAGEN OneStep RT-PCR buffer, 400 μM dNTPs, 0.6 μM gene specific primers, 5U RNase inhibitor and 2 μl of QIAGEN OneStep RT-PCR enzyme mix) for 28 cycles.
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Kudryashev
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Germany

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Photorhabdus* Virulence Cassettes:

extracellular multi-protein needle complexes for delivery of small protein effectors into host cells\" for consideration by *eLife*. Your article has been reviewed by Gisela Storz as the Senior Editor, a Guest Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript describes the packing of the toxin that insect pathogenic bacteria *Photorhabdus* use as a virulence factor into a nanosyringe. *Photorhabdus* Virulence Cassettes (PVC) are evolutionarily related to the Serratia anti-feeding prophage, the *Pseudoalteromonas* MAC system and the bacterial type 6 secretion system. The authors\' computational analysis revealed three classes of PVC systems and identified genes homologous to the MAC gene cluster and to *Burkholderia mallei* T6SS, and they identified putative effectors for the three classes of PVC. One of the effectors, Pnf, was shown to directly associate with the PVC tube, potentially allowing long-range effector delivery following the release of the PVC tube from the bacteria. Addition of PVC*pnf* needle complexes to insect hemocytes led to membrane ruffling and the appearance of \~150 nm long linear structures on the cell surface. The authors further demonstrate that the effector Pnf -- which was previously shown to interfere with actin cytoskeleton of the host cells -- acts by modifying small Rho GTPases RhoA and Rac1 by transglutamination and deamidation.

Overall the manuscript is interesting and advances the understanding of the PVC systems, their relation to the R-type pyocins, MAC and T6SS systems, and the mechanisms of effector action. The data is of high quality and the manuscript is mostly well written. However, some parts of the manuscript are rather convoluted, and several important revisions need to be made before the manuscript can be published. We would welcome a revised manuscript.

Essential revisions:

1\) Bioinformatic analysis identified several features that were, unfortunately, not further tested or discussed in this study e.g. role of potential RfaH operator sequence. Are these elements involved in the heterogeneity reported later in the study? It might be helpful if the authors gave some background on RfaH here (rather than in the Discussion section) to aid in understanding what was done. Moreover, the section on the potential mobility of PVC genetic loci is very speculative.

2\) In order to confirm the in vivo expression of the PVC loci, bacteria containing GFP reporter constructs were injected into Manduca larvae before samples were taken for microscopy. As the *gfpmut2* allele used here encodes a stable derivative of GFP, it is important to know the level of GFP expression in the inoculum and also how long post-injection before samples were taken. Did the bacteria grow in the insect to allow potential dilution of GFP already present in the bacteria? Alternatively, it is possible to use a *gfp* allele encoding an unstable protein e.g. GFP(LVA). The RT-PCR data presented in this supplementary figure are effective in supporting in vivo expression of this locus and should be used as a main text figure.

3\) The reviewers think that more elaborate control of protein quality should be presented in the manuscript. In particular, GFP fusions of the PVC locus from *P. asymbiotica* is expressed in vitro and in vivo was monitored in *P. luminescens*. Are the same regulatory circuits present in *P. luminescens*? For example, the authors do not report any heterogeneity of expression in this heterologous system.

4\) The in vitro experiments in the Results section have not been described rigorously enough and they are hard to follow, particularly in subsection "The Pnf effector protein is physically associated with the PVC needle complex". Was the total protein concentration in the clarified supernatant sample similar to the concentration in the particle preps sample? The statement about the need for chemical or physical disruption of the needle for detection of Pnf needs to be more specific.

5\) The section on the effects of heterologously expressed and purified Pnf on the actin cytoskeleton is missing important controls. The proteins Pnf and Pnf~C190A~ must be folded and of sufficient purity for the experiments to be meaningful. Protein purity and quality could be assessed by SDS-PAGE or anion exchange and/or size exclusion chromatography or CD analysis. It would be interesting to know more about secondary structure content, regions of potential disorder or Pnf, potential membrane association and the motivation for the particular design of the C190A mutant. Please comment on purity and quality of Rho1 and Rac1.

6\) The findings of the manuscript should be discussed with respect to the recently published structure of the PVC (Jiang et al., 2019). Particularly, Figure 1---figure supplement 3 and Figure 1---figure supplement 4 and subsection "The Pnf effector protein is physically associated with the PVC needle complex" should be updated.

7\) The authors could elaborate on the possible mechanism of the release of PVC from the bacterial cells beyond the Discussion section? Are there any toxic effects on the bacteria and are there any potential immunity proteins which potentially could be identified by bioinformatic analysis?

8\) Subsection "A bioinformatic analysis of *pvc* structural operon sequences": the authors\' own phylogenetic analyses are not shown (although relevant analyses are referred to subsequently). Please present the results or delete reference to authors\' unpublished studies.

9\) Figure 1 legend: Not clear if the figure refers to *pvc16* as class II or III? Please clarify this section.

10\) Figure 6 legend: this says there is no activity of the mutant but in the Rac1 image, there is a faint band. \"No Pnf\" controls would be valuable in these figures.

11\) Discussion section: expression in spiracles is mentioned here but was not listed in the Results.

12\) Subsection "Deamidation and Transglutamination of Rho GTPases": the pH is unclear here since the buffer (7.4) and the ethylene diamine (9.0) are both listed but this appears to be the same solution.

13\) The arguments expressed in the Discussion section strongly support that PVCs are more similar to R-type pyocins than to the T6SS. The most important distinction is that there is no membrane complex in the PVC. PVCs have more or a less uniform length and act on the target at a distance, therefore the statement that PVC is less similar to R-type pyocins than to T6SS should be revised.

14\) Please note the *eLife* guidelines for titles: Two-part titles and/or punctuation are to be avoided: "In the interests of style and clarity, the titles of *eLife* research papers should not use colons, dashes, exclamation marks, or brackets (unless needed for scientific reasons). Two-part titles should also be avoided (though some exceptions can be made for Tools and Resources)." Furthermore, authors should avoid acronyms in the title: "Titles of *eLife* research papers should avoid unfamiliar abbreviations or acronyms, or authors should spell out in full or provide a brief explanation for any acronyms." Please revise your title with this advice in mind. A possibility: \"The PVC element of *Photorhabdus asymbiotica* virulence cassettes deliver protein effectors directly into target eukaryotic cells\".

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting the revised version of the manuscript \"The PVC element of *Photorhabdus asymbiotica* virulence cassettes deliver protein effectors directly into target eukaryotic cells\". It has been favourably evaluated by the reviewing editor. The updated version has adequately addressed most of the original concerns of the reviewers; however, a few points still need to be dealt with. The remaining revisions will not affect the conclusions of the manuscript, but some of them will serve as important controls, and others are clarifications in the text to make the manuscript more accessible to the general readers of *eLife*.

In particular, reviewer\'s comment 3 has not been fully addressed. If the authors have the data to support similar heterogeneity levels in the two used strains these should be added and briefly described.

Comment 5: please add the considerations about protein quality of Pnf and Pnf C190A to the text of the manuscript. Please comment on purity and quality of Rho1 and Rac1. We believe that the goal of the question about the secondary structure content has not to suggest that you embark on structure determination, but the computational prediction of secondary structure and a comment on the potential ordered and disordered parts of the protein.

Updated subsection "The Pnf effector protein is physically associated with the PVC needle complex" make statements about expression levels observed by florescent microscopy and refer to \"not shown\" data. Please present this data in the supplementary material and provide quantification for the percentage of green cells.

10.7554/eLife.46259.026

Author response

> Essential revisions:
>
> 1\) Bioinformatic analysis identified several features that were, unfortunately, not further tested or discussed in this study e.g. role of potential RfaH operator sequence. Are these elements involved in the heterogeneity reported later in the study? It might be helpful if the authors gave some background on RfaH here (rather than in the Discussion section) to aid in understanding what was done. Moreover, the section on the potential mobility of PVC genetic loci is very speculative.

We appreciate the reviewer's comments regarding the untested role of RfaH in the regulation of the PVC operons. In attempts to address this, we did in fact try to knock-out the *Photorhabdus luminescens* TT01 *rfaH* gene, using a recombineering strategy, that normally works in our hands for this strain. However, we were not able to delete the gene, despite several attempts, suggesting an essential role in *Photorhabdus*. We also procured an *E. coli rfaH* Keio collection knock out strain, but its unusual cellular morphology and phenotypic behavior led us to believe it was unsuitable for any relevant experiments. We have now included this and a brief discussion of *rfaH* into this Results section as suggested. We accept the reviewer's comment regarding the PVC operon motility and have reduced and simplified this text.

> 2\) In order to confirm the in vivo expression of the PVC loci, bacteria containing GFP reporter constructs were injected into Manduca larvae before samples were taken for microscopy. As the gfpmut2 allele used here encodes a stable derivative of GFP, it is important to know the level of GFP expression in the inoculum and also how long post-injection before samples were taken. Did the bacteria grow in the insect to allow potential dilution of GFP already present in the bacteria? Alternatively, it is possible to use a gfp allele encoding an unstable protein e.g. GFP(LVA). The RT-PCR data presented in this supplementary figure are effective in supporting in vivo expression of this locus and should be used as a main text figure.

In this case, in vitro reporter expression (in LB medium) is only seen in a sub-population of cells, as illustrated by similar constructs shown in Figure 2---figure supplement 1. It should be noted that the blood samples and dissections were performed at 12 hours post infection, after injection of a small inoculum of only 100 CFU as described in the Materials and methods section. This indicates that the bacteria would necessarily have been replicating up to the time of examination (in order to see them at all), greatly increasing their numbers and initiating a normal infection. Thus, in answer to the reviewer's question, the green cells are highly unlikely to represent those initially injected. The microcolonies seen in Figure 2B and bacterial cells in 2A therefore represent the activity of cells undergoing an active infection cycle. We have included text to highlight this.

As suggested by the reviewer, we will move the RT-PCR data shown into a figure in the main text (Figure 2C) to further support our findings relating to in vivo expression.

> 3\) The reviewers think that more elaborate control of protein quality should be presented in the manuscript. In particular, GFP fusions of the PVC locus from P. asymbiotica is expressed in vitro and in vivo was monitored in P. luminescens. Are the same regulatory circuits present in P. luminescens? For example, the authors do not report any heterogeneity of expression in this heterologous system.

As the same cis-encoded potential regulatory elements are seen in homologous operons from all *Photorhabdus* strains (and indeed in other genera such as *Yersinia*) that we have looked at, we have no reason to believe that *P. asymbiotica* ATCC43949 and *P. luminescens* TT01 would have different regulatory circuits for *pvc* expression. In a previous study we compared gene expression and pheno-array activity of TT01 and ATCC43949 (see Mulley et al., 2015). We do indeed see the same heterogeneity of expression in all strains we have looked at when grown at the normal insect infection temperature of 28°C. While in Figure 2---figure supplement 1 we only show the activity of *Pa*^ATCC43949^ promotors in a closely related *P. asymbiotica* strain (*Pa*^PB68^) we also have equivalent data for these reporters in *P. luminescens* TT01 which we excluded for brevity. These could be included in the figure also if it is felt necessary.

> 4\) The in vitro experiments in the Results section have not been described rigorously enough and they are hard to follow, particularly in subsection "The Pnf effector protein is physically associated with the PVC needle complex". Was the total protein concentration in the clarified supernatant sample similar to the concentration in the particle preps sample? The statement about the need for chemical or physical disruption of the needle for detection of Pnf needs to be more specific.

We isolated the needle complexes (NCs) from both the wild-type *Photorhabdus asymbiotica* and *E. coli* cosmid clone (c4DF10) grown in 250 ml of LB media for 16 hrs. The particulate matter including NC was isolated from both cultures as described in Materials and methods section and the NC in both cases was resuspended in 0.5 ml of PBS. The reason we have selected the specific growth phase and culture volume relies on previous studies reporting successful detection of *Photorhabdus* secreted toxins under similar conditions. Detection of secreted Pnf from wild-type *P. asymbiotica*^ATCC43949^ was performed at the same time as the isolation of wild-type NC in a duplicate culture. Bacterial cultures were grown from the same starter culture and under the same conditions. However, for isolation of secreted proteins, the supernatant was filtered through 0.45 μm and 0.22 μm filters to remove any remaining bacteria and particulate matter. Then it was concentrated using 4% TCA overnight at 4°C and the next morning washed and resuspended in 10 ml of 50 mM Tris-HCl pH 7.4. The secreted proteins were further concentrated using Amicon filters with NMWL of 10kDa to 0.5 ml. It should be noted that we cannot really compare the two NC preparations as one relies on the natural expression levels, while the other is constitutive expression on the cosmid clone. The chemical and physical methods of needle complex are we believe self-explanatory. We have included this text in the manuscript.

> 5\) The section on the effects of heterologously expressed and purified Pnf on the actin cytoskeleton is missing important controls. The proteins Pnf and Pnf~C190A~ must be folded and of sufficient purity for the experiments to be meaningful. Protein purity and quality could be assessed by SDS-PAGE or anion exchange and/or size exclusion chromatography or CD analysis. It would be interesting to know more about secondary structure content, regions of potential disorder or Pnf, potential membrane association and the motivation for the particular design of the C190A mutant. Please comment on purity and quality of Rho1 and Rac1.

Both the wild-type and mutant toxoid were produced and purified in the same bacterial expression host from the same constructs and under the same conditions (over-expression for 16 hours at low temperature to facilitate solubility). Both proteins were purified at similar yields and none of them appears to be degraded during purification (checked with SDS-PAGE both run at the same size). In addition, the correct folding of the Pnf WT is supported by the clear expected phenotypes obtained by the protein transfection experiments into mammalian cells. It remains formally possible that the toxoid no longer folds correctly, but we would argue that this would only be the equivalent as a heat denatured control. We suggest that determination of the actual structure of the proteins is a little over the top, and not something routinely done in analogous published studies.

> 6\) The findings of the manuscript should be discussed with respect to the recently published structure of the PVC (Jiang et al., 2019). Particularly, Figure 1---figure supplement 3 and Figure 1---figure supplement 4 and subsection "The Pnf effector protein is physically associated with the PVC needle complex" should be updated.

We have now modified the text to include reference to this recent publication as requested. We have also improved Figure 1---figure supplement 3 and Figure 1---figure supplement 4 to include a more up to date HHPRED analysis table that is colour coded to match that used in the PVC structure publication. In addition, we have modified the text in subsection "The Pnf effector protein is physically associated with the PVC needle complex" and subsection "The Pnf protein requires delivery into the eukaryotic cell cytoplasm to exert its

Effect" to discuss the location of the Pvc2 anti peptide antibody epitope in relation to the recently published structure.

> 7\) The authors could elaborate on the possible mechanism of the release of PVC from the bacterial cells beyond the Discussion section? Are there any toxic effects on the bacteria and are there any potential immunity proteins which potentially could be identified by bioinformatic analysis?

We have expanded the text in this section in response to the reviewer's suggestion. In unpublished work we have data to suggest that either a restricted small sub-population can produce very large quantities of PVCs, that are released by lysis, or that the needle complex can in fact be secreted. We hope this work will form part of a subsequent publication.

We do discuss toxic effects of unregulated PVC expression in the heterologous *E. coli* cosmid expression strains in the manuscript. We do have loss of viability data in *E. coli* we could include if deemed necessary. In addition, we have tested purified PVC*pnf* needle complexes themselves against a range of different bacteria genera, and saw no toxicity, or indeed even cell surface binding using TEM studies. We mention this in the Discussion section. It does not seem useful for us to include this "negative" data however.

As such we do not really understand the question regarding immunity proteins. As mentioned above, unlike Type 6 secretion systems, the PVCs do not appear to target other bacteria. As such the toxins they deliver are apparently evolved against eukaryotic targets. Therefore, there is no assumed requirement for immunity proteins for the expression of PVCs (and their cognate toxins) in the bacteria themselves.

> 8\) Subsection "A bioinformatic analysis of pvc structural operon sequences": the authors\' own phylogenetic analyses are not shown (although relevant analyses are referred to subsequently). Please present the results or delete reference to authors\' unpublished studies.

We do not wish to increase the complexity and size of the publication further so as suggested by the reviewer we have removed the reference to our unpublished phylogenetic analysis.

> 9\) Figure 1 legend: Not clear if the figure refers to pvc16 as class II or III? Please clarify this section.

We have edited the figure legend text to improve consistency and clarity and hope this addresses the issue.

> 10\) Figure 6 legend: this says there is no activity of the mutant but in the Rac1 image, there is a faint band. \"No Pnf\" controls would be valuable in these figures.

The specificity of the anti-63 polyclonal against the exact same constructs (not only plasmids but also expression host) has been shown in McNichol et al. (2006) paper Figure 6, where we can see a faint non-specific band for both RhoA and Rac1 incubated without toxin (lane 1 on western blot panels). The only way to address this with any precision may be to use 2D electrophoresis and/or MS analysis as deamidation of glutamine alters the isoelectric point (pI) of the protein. We feel this additional effort would not really add much to the manuscript.

> 11\) Discussion section: expression in spiracles is mentioned here but was not listed in the Results.

Apologies, this was an error and the comment in the discussion has now be changed to "insect trachea".

> 12\) Subsection "Deamidation and Transglutamination of Rho GTPases": the pH is unclear here since the buffer (7.4) and the ethylene diamine (9.0) are both listed but this appears to be the same solution.

Please note that the addition of ethylenediamine increased the pH to 9.

> 13\) The arguments expressed in the Discussion section strongly support that PVCs are more similar to R-type pyocins than to the T6SS. The most important distinction is that there is no membrane complex in the PVC. PVCs have more or a less uniform length and act on the target at a distance, therefore the statement that PVC is less similar to R-type pyocins than to T6SS should be revised.

In response to the first comment here, we believe the reviewer may have misread this as the sentence referred to actually says; "An analysis of the different subunit proteins of PVCs show they share several elements in common with other contractile phage-tail derived systems, including the Type VI secretion system (T6SS) (Leiman et al., 2010) and to a lesser extent R-type pyocins (Russell et al., 2014)."

We argue that we do highlight these differences/similarities between the PVCs and T6SS and R-type pyocins in a clear way. While the lack of membrane complex, standardised length and action at a distance are indeed more reminiscent of R-type pyocins, genetically PVCs are in many respects more like T6SS than the more phage-like pyocins. Nevertheless, we have made minor modification to this text to clarify this.

> 14\) Please note the eLife guidelines for titles: Two-part titles and/or punctuation are to be avoided: "In the interests of style and clarity, the titles of eLife research papers should not use colons, dashes, exclamation marks, or brackets (unless needed for scientific reasons). Two-part titles should also be avoided (though some exceptions can be made for Tools and Resources)." Furthermore, authors should avoid acronyms in the title: "Titles of eLife research papers should avoid unfamiliar abbreviations or acronyms, or authors should spell out in full or provide a brief explanation for any acronyms." Please revise your title with this advice in mind. A possibility: \"The PVC element of Photorhabdus asymbiotica virulence cassettes deliver protein effectors directly into target eukaryotic cells\".

We are happy to adopt the new title suggested.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

In particular, reviewer\'s comment 3 has not been fully addressed. If the authors have the data to support similar heterogeneity levels in the two used strains these should be added and briefly described.

We have now expanded the Figure 2 supplementary material to include representative micrographs from a time course of reporter activity from four PVC operons from each of two species, *P. luminescens*^TT01^ and *P. asymbiotica*^PB68.1^ (so a total of 8 PVC operons now). These can be viewed as Figure 2---figure supplement 3 and Figure 2---figure supplement 4. We have also now added pertinent descriptive text to the manuscript and expanded the Materials and methods section to include construction of the additional seven plasmids (including a primer list as a supplementary document).

> Comment 5: please add the considerations about protein quality of Pnf and Pnf C190A to the text of the manuscript. Please comment on purity and quality of Rho1 and Rac1. We believe that the goal of the question about the secondary structure content has not to suggest that you embark on structure determination, but the computational prediction of secondary structure and a comment on the potential ordered and disordered parts of the protein.

We have now added comments regarding the methods used and purity of the various protein preparations. In addition, we have performed Phyre2 computational structural predictions of the wild-type Pnf and toxoid sequences. We have added text to discuss that the single amino acid change in the Pnf active site (C190A) causes minimal overall predicted structural differences in the two proteins. A summary figure has now been included as Figure 6---figure supplement 1 to illustrate a comparison of these models.

> Updated subsection "The Pnf effector protein is physically associated with the PVC needle complex" make statements about expression levels observed by florescent microscopy and refer to \"not shown\" data. Please present this data in a supplementary material and provide quantification for the percentage of green cells.

We have now included an image analysis (Figure 2---figure supplement 2) to objectively quantify heterogeneity of GFP expression in the reporter strain shown in Figure 2---figure supplement 1. A description is included in the text and methods included in the figure legend. We also include the raw data as an excel file.

[^1]: These authors contributed equally to this work.
